Voloridge Investment Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-431,150
| Closed | -$1.13M | – | 1336 |
|
|
2025
Q1 | $1.13M | Sell |
431,150
-192,189
| -31% | -$504K | ﹤0.01% | 1034 |
|
|
2024
Q4 | $2.57M | Sell |
623,339
-607,037
| -49% | -$2.5M | 0.01% | 912 |
|
|
2024
Q3 | $8.71M | Buy |
1,230,376
+39,193
| +3% | +$277K | 0.03% | 626 |
|
|
2024
Q2 | $7.77M | Buy |
1,191,183
+984,427
| +476% | +$6.42M | 0.03% | 634 |
|
|
2024
Q1 | $1.72M | Sell |
206,756
-19,556
| -9% | -$162K | 0.01% | 883 |
|
|
2023
Q4 | $2.49M | Buy |
226,312
+82,590
| +57% | +$909K | 0.01% | 781 |
|
|
2023
Q3 | $1.21M | Buy |
+143,722
| New | +$1.21M | 0.01% | 1058 |
|
|
2023
Q1 | – | Sell |
-17,835
| Closed | -$266K | – | 1577 |
|
|
2022
Q4 | $266K | Sell |
17,835
-294,749
| -94% | -$4.4M | ﹤0.01% | 1350 |
|
|
2022
Q3 | $6.99M | Buy |
312,584
+268,406
| +608% | +$6M | 0.04% | 545 |
|
|
2022
Q2 | $740K | Buy |
44,178
+37,064
| +521% | +$621K | ﹤0.01% | 1254 |
|
|
2022
Q1 | $213K | Buy |
+7,114
| New | +$213K | ﹤0.01% | 1298 |
|
|
2021
Q4 | – | Sell |
-70,253
| Closed | -$2.22M | – | 1809 |
|
|
2021
Q3 | $2.22M | Sell |
70,253
-79,129
| -53% | -$2.49M | 0.01% | 1023 |
|
|
2021
Q2 | $5.47M | Sell |
149,382
-49,988
| -25% | -$1.83M | 0.04% | 608 |
|
|
2021
Q1 | $6.89M | Buy |
+199,370
| New | +$6.89M | 0.05% | 432 |
|